FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992079605> ?p ?o ?g. }

• W1992079605 endingPage "110" @default.
• W1992079605 startingPage "103" @default.
• W1992079605 abstract "Clinical application of an antibiotic’s pharmacokinetic/pharmacodynamic (PK/PD) properties may improve the outcome of severe infections. No data are available on the use of linezolid (LNZ) continuous infusion in critically ill obese patients affected by ventilator-associated pneumonia (VAP). We conducted a prospective randomized controlled trial to compare LNZ concentrations in plasma and epithelial lining fluid (ELF), when administered by intermittent and continuous infusion (II, CI), in obese critically ill patients affected by VAP. Twenty-two critically ill obese patients were enrolled. At the steady state, in the II group, mean ± SD total and unbound maximum–minimum concentrations (C max/C max,u − C min/Cmin,u) were 10 ± 3.7/6.8 ± 2.6 mg/L and 1.7 ± 1.1/1.2 ± 0.8 mg/L, respectively. In the CI group, the mean ± SD total and unbound plasma concentrations (C ss and C ss,u) were 6.2 ± 2.3 and 4.3 ± 1.6 mg/L, respectively. Within a minimum inhibitory concentration (MIC) range of 1–4 mg/L, the median (IQR) time LNZ plasma concentration persisted above MIC (% T > MIC) was significantly higher in the CI than the II group [100 (100–100) vs 100 (89–100), p = 0.05; 100 (100–100) vs 82 (54.8–98.8), p = 0.009; 100 (74.2–100) vs 33 (30.2–78.5), p = 0.005; respectively]. Pulmonary penetration (%) was higher in the CI group, as confirmed by a Monte Carlo simulation [98.8 (IQR 93.8–104.3) vs 87.1 (IQR 78.7–95.4); p < 0.001]. In critically ill obese patients affected by VAP, LNZ CI may overcome the limits of standard administration but these advantages are less evident with difficult to treat pathogens (MIC = 4 mg/L). These data support the usefulness of LNZ continuous infusion, combined with therapeutic drug monitoring (TDM), in selected critically ill populations." @default.
• W1992079605 created "2016-06-24" @default.
• W1992079605 creator A5005123862 @default.
• W1992079605 creator A5030961669 @default.
• W1992079605 creator A5037989578 @default.
• W1992079605 creator A5040558981 @default.
• W1992079605 creator A5048017448 @default.
• W1992079605 creator A5049569770 @default.
• W1992079605 creator A5052945443 @default.
• W1992079605 creator A5069889138 @default.
• W1992079605 creator A5070607915 @default.
• W1992079605 creator A5075311040 @default.
• W1992079605 creator A5079254115 @default.
• W1992079605 date "2014-11-21" @default.
• W1992079605 modified "2023-10-01" @default.
• W1992079605 title "Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration" @default.
• W1992079605 cites W1509503837 @default.
• W1992079605 cites W1567981081 @default.
• W1992079605 cites W1976771130 @default.
• W1992079605 cites W1979122840 @default.
• W1992079605 cites W1982720496 @default.
• W1992079605 cites W2011813012 @default.
• W1992079605 cites W2023352133 @default.
• W1992079605 cites W2026827322 @default.
• W1992079605 cites W2026928559 @default.
• W1992079605 cites W2031069021 @default.
• W1992079605 cites W2074305976 @default.
• W1992079605 cites W2078446310 @default.
• W1992079605 cites W2079827630 @default.
• W1992079605 cites W2082321986 @default.
• W1992079605 cites W2087072928 @default.
• W1992079605 cites W2091685798 @default.
• W1992079605 cites W2097006353 @default.
• W1992079605 cites W2101416655 @default.
• W1992079605 cites W2101480609 @default.
• W1992079605 cites W2103008889 @default.
• W1992079605 cites W2118901469 @default.
• W1992079605 cites W2120444754 @default.
• W1992079605 cites W2121757359 @default.
• W1992079605 cites W2123259040 @default.
• W1992079605 cites W2125096244 @default.
• W1992079605 cites W2132999210 @default.
• W1992079605 cites W2144143337 @default.
• W1992079605 cites W2145138274 @default.
• W1992079605 cites W2149005123 @default.
• W1992079605 cites W2154805978 @default.
• W1992079605 cites W2161206754 @default.
• W1992079605 doi "https://doi.org/10.1007/s00134-014-3550-y" @default.
• W1992079605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25413377" @default.
• W1992079605 hasPublicationYear "2014" @default.
• W1992079605 type Work @default.
• W1992079605 sameAs 1992079605 @default.
• W1992079605 citedByCount "36" @default.
• W1992079605 countsByYear W19920796052014 @default.
• W1992079605 countsByYear W19920796052015 @default.
• W1992079605 countsByYear W19920796052016 @default.
• W1992079605 countsByYear W19920796052017 @default.
• W1992079605 countsByYear W19920796052018 @default.
• W1992079605 countsByYear W19920796052019 @default.
• W1992079605 countsByYear W19920796052020 @default.
• W1992079605 countsByYear W19920796052021 @default.
• W1992079605 countsByYear W19920796052022 @default.
• W1992079605 countsByYear W19920796052023 @default.
• W1992079605 crossrefType "journal-article" @default.
• W1992079605 hasAuthorship W1992079605A5005123862 @default.
• W1992079605 hasAuthorship W1992079605A5030961669 @default.
• W1992079605 hasAuthorship W1992079605A5037989578 @default.
• W1992079605 hasAuthorship W1992079605A5040558981 @default.
• W1992079605 hasAuthorship W1992079605A5048017448 @default.
• W1992079605 hasAuthorship W1992079605A5049569770 @default.
• W1992079605 hasAuthorship W1992079605A5052945443 @default.
• W1992079605 hasAuthorship W1992079605A5069889138 @default.
• W1992079605 hasAuthorship W1992079605A5070607915 @default.
• W1992079605 hasAuthorship W1992079605A5075311040 @default.
• W1992079605 hasAuthorship W1992079605A5079254115 @default.
• W1992079605 hasBestOaLocation W19920796051 @default.
• W1992079605 hasConcept C111113717 @default.
• W1992079605 hasConcept C112705442 @default.
• W1992079605 hasConcept C119060515 @default.
• W1992079605 hasConcept C126322002 @default.
• W1992079605 hasConcept C176947019 @default.
• W1992079605 hasConcept C188816634 @default.
• W1992079605 hasConcept C22979827 @default.
• W1992079605 hasConcept C2777184939 @default.
• W1992079605 hasConcept C2777914695 @default.
• W1992079605 hasConcept C2778335254 @default.
• W1992079605 hasConcept C2778980435 @default.
• W1992079605 hasConcept C2779489039 @default.
• W1992079605 hasConcept C2781414143 @default.
• W1992079605 hasConcept C2991859549 @default.
• W1992079605 hasConcept C42219234 @default.
• W1992079605 hasConcept C501593827 @default.
• W1992079605 hasConcept C523546767 @default.
• W1992079605 hasConcept C54355233 @default.
• W1992079605 hasConcept C71924100 @default.
• W1992079605 hasConcept C86803240 @default.
• W1992079605 hasConcept C89423630 @default.
• W1992079605 hasConcept C90924648 @default.

• next